Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Raw Materials (2021 - 2025)

Historic Raw Materials for Veracyte (VCYT) over the last 5 years, with Q3 2025 value amounting to $20.3 million.

  • Veracyte's Raw Materials rose 2559.94% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 2559.94%. This contributed to the annual value of $17.9 million for FY2024, which is 34690.0% up from last year.
  • Latest data reveals that Veracyte reported Raw Materials of $20.3 million as of Q3 2025, which was up 2559.94% from $20.1 million recorded in Q2 2025.
  • Veracyte's 5-year Raw Materials high stood at $20.3 million for Q3 2025, and its period low was $3.0 million during Q4 2021.
  • Its 5-year average for Raw Materials is $8.9 million, with a median of $4.2 million in 2022.
  • Per our database at Business Quant, Veracyte's Raw Materials tumbled by 681.82% in 2023 and then surged by 34690.0% in 2024.
  • Quarter analysis of 5 years shows Veracyte's Raw Materials stood at $3.0 million in 2021, then skyrocketed by 36.67% to $4.1 million in 2022, then dropped by 2.44% to $4.0 million in 2023, then soared by 346.9% to $17.9 million in 2024, then increased by 13.71% to $20.3 million in 2025.
  • Its Raw Materials stands at $20.3 million for Q3 2025, versus $20.1 million for Q2 2025 and $18.4 million for Q1 2025.